Zhong Yuan Bio-Technology Holdings Partners with Taiwan Technology Industry Association to Promote Research on Nervonic Acid Intervention for Parkinson's Disease

• Date：2024-06-12

• By：

Recently, at the Beijing-Taiwan Brain Health Academic Symposium ( also known as the Beijing-Taiwan Young Scientists Forum), Zhong Yuan Bio-Technology Holdings made a significant impression and formally signed an agreement with Academician Lin Zhe'an, Chairman of the Taiwan Technology Industry Association, to jointly conduct research on Nervonic acid intervention for Parkinson's disease.

On May 13, the Beijing-Taiwan Brain Health Academic Symposium were grandly held in Beijing. Organized by the Zhongguancun Industry Technology Alliance Federation and hosted by HICOOL, the symposium aimed to expand and deepen high-quality cooperation between Beijing and Taiwan in the field of brain health and other technological innovations. The event provided a platform for communication, exchange, and in-depth collaboration. It aimed to promote practical cooperation in the field of science and technology across the Taiwan Strait, facilitate the transformation and application of scientific and technological achievements, and promote the coordinated development of the tech industries on both sides.

Chang Tingting, CEO of Zhong Yuan Bio-Technology Holdings and a leading figure in the industry, was invited to attend the event and share the company's developments in the field of brain health. Following this, Dr. Chen Xianyang, Chief Technology Officer of Zhong Yuan Bio-Technology Holdings, reported on the group's research progress and the prospects of Nervonic acid for the intervention and treatment of Parkinson's disease. Additionally, Zhang Yan, Director of Drug Development, and Dr. Ikuba, a postdoctoral researcher from Bao Feng Biotech, explained the pathways for developing drug targets. Academician Lin expressed high appreciation for the research achievements of Zhong Yuan Bio-Technology Holdings and looked forward to more breakthrough results in their future collaboration.

During the interaction session, Zhong Yuan Bio-Technology Holdings engaged in in-depth discussions with representatives of companies and projects from the brain health sector in Beijing and Taiwan. They showcased their latest technological innovations in the biopharmaceutical field. Participants expressed that this forum provided a valuable platform for exchange between the scientific and industrial communities across the Taiwan Strait, contributing to the promotion of cooperation and development in the field of brain health.

The collaboration between Zhong Yuan Bio-Technology Holdings and the Taiwan Technology Industry Association not only demonstrates the company's strength in neuroscience research but also injects new momentum into its future development. Zhong Yuan Bio-Technology Holdings will further advance the application research of nervonic acid in the treatment of Parkinson's disease, bringing hope to patients. The company will continue to increase its investment in neuroscience research, promote the production of more innovative results, and make greater contributions to human health.